CX3CR1-deficiency is associated with increased severity of disease in experimental autoimmune uveitis.
The role of CX3CR1 in regulating the function of monocytes and microglia was examined in mice in which CX3CR1 had been replaced by green fluorescent protein (GFP). Induction of experimental autoimmune uveitis (EAU) in these mice resulted in increased disease severity at day 23 postimmunization with uveitogenic peptide when compared with CX3CR1-positive mice and increased apoptosis of neuronal cells in the inner nuclear layer. Resident microglia within the retina were activated equally as EAU developed in mice with or without CX3CR1, as determined by changes in morphology, suggesting that the microglial cell response did not account for the differences. Although the inflammatory infiltrate had increased in mice without CX3CR1 at day 23 postimmunization, the percentage of natural killer cells in the infiltrate was not changed in these mice. Similarly, increased disease severity at this stage was not associated with an overall increased percentage of macrophages in the retinal inflammatory infiltrate or in increased activation of these cells. The increased recruitment of monocytes to the retina in response to EAU induction in CX3CR1(GFP/GFP) mice compared with CX3CR1(GFP/+) mice was not reflected in increased migration away from vessels, leading to marked clustering of GFP(+) cells around veins and venules in these mice. It is possible that this monocyte/macrophage clustering leads to the increased severity of disease seen in the mice by focusing and so intensifying the inflammatory response.
Dagkalis
Athanasios
A
Division of Applied Medicine, University of Aberdeen, Aberdeen, UK.
Wallace
Carol
C
Hing
Benjamin
B
Liversidge
Janet
J
Crane
Isabel J
IJ
D000818:Animals; D017209:Apoptosis / Q000276:immunology; D001327:Autoimmune Diseases / Q000276:immunology* / Q000473:pathology; D000073883:CX3C Chemokine Receptor 1; D007694:Killer Cells, Natural / Q000276:immunology; D008262:Macrophage Activation / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D017628:Microglia / Q000276:immunology; D009000:Monocytes / Q000276:immunology; D019707:Receptors, Chemokine / Q000172:deficiency* / Q000235:genetics / Q000276:immunology; D012160:Retina / Q000276:immunology / Q000473:pathology; D014605:Uveitis / Q000276:immunology* / Q000473:pathology
D000073883:CX3C Chemokine Receptor 1; C471885:Cx3cr1 protein, mouse; D019707:Receptors, Chemokine
FASEB J. 2006 May;20(7):896-905
16675847
Curr Eye Res. 1998 Apr;17(4):426-37
9561835
Invest Ophthalmol Vis Sci. 1999 Dec;40(13):3177-85
10586940
J Clin Invest. 2007 Apr;117(4):902-9
17364026
Annu Rev Immunol. 2004;22:891-928
15032599
Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1608-15
12657599
J Immunol. 1999 Aug 1;163(3):1628-35
10415068
J Leukoc Biol. 2006 Mar;79(3):435-43
16365158
Kidney Int. 1999 Aug;56(2):612-20
10432400
J Clin Invest. 1997 Nov 15;100(10):2552-61
9366570
J Immunol. 2000 Jul 1;165(1):397-403
10861077
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7958-63
11438742
Am J Pathol. 2002 Nov;161(5):1669-77
12414514
J Clin Invest. 2003 Feb;111(3):333-40
12569158
J Immunol. 2002 Mar 1;168(5):2483-92
11859142
Circulation. 2003 Feb 25;107(7):1009-16
12600915
J Neuroimmunol. 2002 Apr;125(1-2):59-65
11960641
Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8075-80
10869418
Nat Immunol. 2006 Mar;7(3):311-7
16462739
J Clin Invest. 2007 Oct;117(10):2920-8
17909628
J Immunol. 2001 Jun 1;166(11):6477-82
11359797
Immunity. 2003 Jul;19(1):71-82
12871640
Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1547-52
11381059
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10896-901
9724801
J Immunol. 2004 Apr 1;172(7):4410-7
15034056
Brain Res. 2003 Jul 25;979(1-2):65-70
12850572
Nat Neurosci. 2006 Jul;9(7):917-24
16732273
J Mol Med (Berl). 2005 Sep;83(9):672-81
15827759
J Leukoc Biol. 2002 Dec;72(6):1117-21
12488492
Invest Ophthalmol Vis Sci. 2003 Jan;44(1):22-31
12506051
J Exp Med. 2000 Oct 2;192(7):1075-80
11015448
Glia. 2001 Mar 1;33(3):256-66
11241743
Microsc Res Tech. 1997 Jan 1;36(1):1-16
9031257
J Neurosci Res. 2005 Aug 1;81(3):302-13
15954124
Glia. 1999 Dec;28(3):183-9
10559777
Nat Neurosci. 2005 Jun;8(6):752-8
15895084
Eur J Immunol. 2003 Feb;33(2):402-10
12645937
J Clin Invest. 2007 Jan;117(1):185-94
17200718
Methods. 2006 Feb;38(2):69-76
16414268
Mol Cell Biol. 2000 Jun;20(11):4106-14
10805752
Glia. 2000 Feb 15;29(4):305-15
10652441
Science. 2007 Aug 3;317(5838):666-70
17673663
Nat Rev Immunol. 2005 Dec;5(12):953-64
16322748
Glia. 1996 Jan;16(1):81-90
8787776
J Clin Invest. 2004 Mar;113(6):856-66
15067318
Science. 2005 May 27;308(5726):1314-8
15831717